Brevan Howard Capital Management’s Regenxbio RGNX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-17,373	Closed	-$124K	–	1893
2025 Q1	$124K	Sell	17,373 -23,787	-58%	-$170K	﹤0.01%	992
2024 Q4	$318K	Buy	+41,160	New	+$318K	﹤0.01%	723
2024 Q3	–	Sell	-15,222	Closed	-$178K	–	1339
2024 Q2	$178K	Buy	+15,222	New	+$178K	﹤0.01%	866